Assistant Professor, Dept. of Neurology – University of Michigan Medical School
Amro Stino, MD is an Assistant Professor in the Department of Neurology in the University of Michigan Medical School, Division of Neuromuscular Medicine. Dr. Stino has expertise in the treatment of neuromuscular disorders, with special clinical and research interest in the care of patients with acquired and hereditary peripheral neuropathy.
Dr. Stino obtained his Bachelor of Science degree in Brain, Behavioral, and Cognitive Sciences from the University of Michigan, Ann Arbor, which he completed in 2006. He received his medical degree from Wayne State University, School of Medicine in Detroit, MI in 2010 and completed a transitional year internship at St. Joseph Mercy Hospital, in Ann Arbor, MI. He then completed his neurology residency training at the Wayne State University, School of Medicine – Detroit Medical Center, followed by a fellowship in clinical neurophysiology / neuromuscular medicine at The Mayo Clinic in Arizona. He joined The Ohio State University faculty in 2015 as Director of the Peripheral Neuropathy Clinic and Autonomic Lab. During his time there, he oversaw expansion of diagnostic testing and clinical operations of both, helping provide more comprehensive neuropathy care for central and southern Ohio patients seeking multi-disciplinary neuropathy care. He helped obtain CMT center of excellence accreditation. While at Ohio State, he served as site investigator in the Pharnext PXT3003 trial in CMT1A. He also conducted an investigator initiated study evaluating the diagnostic value of foot architecture in CMT. He joined the University of Michigan faculty in 2019 as Director of the Peripheral Neuropathy clinic and Co-director of the Autonomic Lab. Currently, he remains actively involved in CMT research. He serves as site principal investigator on multi-center studies and is leading an investigator initiated phase 1b study as well. Dr. Stino is an advocate for patient awareness and education in neuropathy through patient advocacy organizations.